Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid
- PMID: 18373647
- DOI: 10.1111/j.1742-7843.2007.00155.x
Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid
Abstract
Perfluorooctanoic acid, an environmental contaminant, is found in both wild animals and human beings. There are large species and sex differences in the renal excretion of perfluorooctanoic acid. In the present study, we aimed to characterize organic anion transporters 1-3 (OAT1-3) in human beings and rats to investigate whether the species differences in the elimination kinetics of perfluorooctanoic acid from the kidneys can be attributed to differences in the affinities of these transporters for perfluorooctanoic acid. We used human (h) and rat (r) OAT transient expression cell systems and measured the [(14)C] perfluorooctanoic acid transport activities. Both human and rat OAT1 and OAT3 mediated perfluorooctanoic acid transport to similar degrees. Specifically, the kinetic parameters, K(m), were 48.0 +/- 6.4 microM for h OAT1; 51.0 +/- 12.0 microM for rOAT1; 49.1 +/- 21.4 microM for hOAT3 and 80.2 +/- 17.8 microM for rOAT3, respectively. These data indicate that both human and rat OAT1 and OAT3 have high affinities for perfluorooctanoic acid and that the species differences in its renal elimination are not attributable to affinity differences in these OATs between human beings and rats. In contrast, neither hOAT2 nor rOAT2 transported perfluorooctanoic acid. In conclusion, OAT1 and OAT3 mediated perfluorooctanoic acid transport in vitro, suggesting that these transporters also transport perfluorooctanoic acid through the basolateral membrane of proximal tubular cells in vivo in both human beings and rats. Neither human nor rat OAT2 mediated perfluorooctanoic acid transport. Collectively, the difference between the perfluorooctanoic acid half-lives in human beings and rats is not likely to be attributable to differences in the affinities of these transporters for perfluorooctanoic acid.
Similar articles
-
A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.J Pharmacol Exp Ther. 2005 Oct;315(1):337-45. doi: 10.1124/jpet.105.088104. Epub 2005 Jul 8. J Pharmacol Exp Ther. 2005. PMID: 16006492
-
Transport of organic anions across the basolateral membrane of proximal tubule cells.Rev Physiol Biochem Pharmacol. 2003;146:95-158. doi: 10.1007/s10254-002-0003-8. Epub 2003 Jan 30. Rev Physiol Biochem Pharmacol. 2003. PMID: 12605306 Review.
-
Prostaglandin E2 inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3.J Am Soc Nephrol. 2006 Jan;17(1):46-53. doi: 10.1681/ASN.2005070727. Epub 2005 Dec 7. J Am Soc Nephrol. 2006. PMID: 16338963
-
Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels.Drug Metab Dispos. 2004 Jun;32(6):620-5. doi: 10.1124/dmd.32.6.620. Drug Metab Dispos. 2004. PMID: 15155553
-
Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.Pharmacol Ther. 2006 Mar;109(3):399-412. doi: 10.1016/j.pharmthera.2005.07.005. Epub 2005 Sep 16. Pharmacol Ther. 2006. PMID: 16169085 Review.
Cited by
-
IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.Toxics. 2022 May 1;10(5):232. doi: 10.3390/toxics10050232. Toxics. 2022. PMID: 35622645 Free PMC article. Review.
-
Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.Toxicol Appl Pharmacol. 2022 May 1;442:115991. doi: 10.1016/j.taap.2022.115991. Epub 2022 Mar 23. Toxicol Appl Pharmacol. 2022. PMID: 35337807
-
Understanding the dynamics of physiological changes, protein expression, and PFAS in wildlife.Environ Int. 2022 Jan 15;159:107037. doi: 10.1016/j.envint.2021.107037. Epub 2021 Dec 9. Environ Int. 2022. PMID: 34896671 Review.
-
Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.Environ Int. 2021 Dec;157:106789. doi: 10.1016/j.envint.2021.106789. Epub 2021 Jul 29. Environ Int. 2021. PMID: 34333293
-
Derivation of a Human In Vivo Benchmark Dose for Perfluorooctanoic Acid From ToxCast In Vitro Concentration-Response Data Using a Computational Workflow for Probabilistic Quantitative In Vitro to In Vivo Extrapolation.Front Pharmacol. 2021 May 11;12:630457. doi: 10.3389/fphar.2021.630457. eCollection 2021. Front Pharmacol. 2021. PMID: 34045957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
